Trial intelligence / Profile preview

Xiaoer Foshao Hezhong Granules in Pediatric Functional Abdominal Pain

CTR20241384Phase 2Completed

Sponsor
Jiangsu Kanion Pharmaceutical Co., Ltd.
Start
Apr 2024
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of xiaoer foshao hezhong in functional abdominal pain syndrome (CAPS), sponsored by Jiangsu Kanion Pharmaceutical Co., Ltd.. Started Apr 2024; status: completed.

02

Drugs

xiaoer foshao hezhong
03

Conditions

functional abdominal pain syndrome (CAPS)

Beyond the preview

Go deeper on CTR20241384.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on CTR20241384.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call